跳至主要内容
临床试验/EUCTR2012-003391-39-FR
EUCTR2012-003391-39-FR
进行中(未招募)
1 期

Ballon aortic valvuloplasty performed without heparin to decrease vascular and bleeding complications of the procedure - HEPAVALV

niversity Hospital of Montpellier0 个研究点目标入组 130 人2012年9月24日

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
Aortic stenosis
发起方
niversity Hospital of Montpellier
入组人数
130
状态
进行中(未招募)
最后更新
5年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2012年9月24日
结束日期
待定
最后更新
5年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

发起方
niversity Hospital of Montpellier

入排标准

入选标准

  • Patients must :
  • \- be over 18 and carry a tight and symptomatic aortic stenosis
  • \- have an indication for a balloon aortic valvuloplasty
  • \- be informed about the study and have given his written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 130
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 100

排除标准

  • Patients must not :
  • \- have an absence of femoral surgical approach
  • \- have a critical hemodynamic state, considered as outdrove for the treatment
  • \- have a severe aortic failure
  • \- be allergic to heparin
  • \- have a contraindication to the use of heparin
  • \- have a contraindication to local anaesthetic
  • \- be treated by low molecular weight heparin in less than 12 hours before the valvuloplasty or by standard heparin in less than 4 hours before the valvuloplasty
  • \- have a tight but not symptomatic aortic stenosis
  • \- be pregnant, breast\-feeding, with no rights from the national health insurance programme

结局指标

主要结局

未指定

相似试验